Chemoinformaics analysis of 2-Methyl-3-phenyl-1-propene
Molecular Weight | 132.206 | nRot | 2 |
Heavy Atom Molecular Weight | 120.11 | nRig | 7 |
Exact Molecular Weight | 132.094 | nRing | 1 |
Solubility: LogS | -3.416 | nHRing | 0 |
Solubility: LogP | 3.443 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
nHA | 0 | APOL | 24.7015 |
nHD | 0 | BPOL | 12.0385 |
QED | 0.543 |
Synth | 1.642 |
Natural Product Likeliness | -0.136 |
NR-PPAR-gamma | 0.015 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -4.229 |
MDCK | 0.0000404 |
BBB | 0.984 |
PPB | 0.762469 |
VDSS | 2.118 |
FU | 0.182932 |
CYP1A2-inh | 0.719 |
CYP1A2-sub | 0.426 |
CYP2c19-inh | 0.668 |
CYP2c19-sub | 0.591 |
CYP2c9-inh | 0.211 |
CYP2c9-sub | 0.209 |
CYP2d6-inh | 0.018 |
CYP2d6-sub | 0.353 |
CYP3a4-inh | 0.026 |
CYP3a4-sub | 0.352 |
CL | 12.682 |
T12 | 0.71 |
hERG | 0.025 |
Ames | 0.046 |
ROA | 0.014 |
SkinSen | 0.27 |
Carcinogencity | 0.82 |
EI | 0.989 |
Respiratory | 0.055 |
NR-Aromatase | 0.006 |
Antiviral | No |
Prediction | 0.90496 |